Abstract
This study examined the impact of eliminating intramuscular PRN medication for agitation on patient and staff safety in an acute psychiatric inpatient setting. The current retrospective chart review investigated the use of PRN medications (oral and intramuscular) to treat acute agitation, including aggression, and related outcomes before and after a mandated change in PRN practice that required real time physician input before administration of intramuscular medications. The use of both oral and intramuscular PRN medications dramatically decreased following implementation of the mandated change in practice. In particular, the use of intramuscular PRNs for agitation decreased by about half. Despite this decrease, the assault rate in the hospital was unchanged, and the utilization of restraint and seclusion continued to decrease. It is possible to reduce the utilization of PRN medications for agitation without broadly compromising safety on acute care psychiatric inpatient units.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Usher K, Lindsay D, Sellen J. Mental health nurses’ PRN psychotropic medication administration practices. J Psychiatr Ment Health Nurs. 8:383–390, 2001.
Thapa P, Palmer S, Owen R, Huntley A, Clardy J, Miller L. PRN (as-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications. Psychiat Serv. 5:1282–1286, 2003.
Stein-Parbury J, Reid K; Smith N, Mouhanna D, Lamont F. Use of pro re nata medications in acute inpatient care. Aust N Z J Psychiatry. 42:283–292, 2008.
Srivastava A. Limited evidence for the effectiveness of p.r.n. Medications among psychiatric inpatients. J Psychiatr Pract. 3:193–201, 2009.
Hilton MF, Whiteford HA. Pro re nata medication for psychiatric inpatients: time to act. Aust N Z J Psychiatry 42:555–564, 2008.
Smith GM, Davis RH, Altenor A, Tran DP, Wolfe KL, Deegan JA, Bradley J. Psychiatric use of unscheduled medications in the Pennsylvania state hospital system: effects of discontinuing the use of P.R.N. orders. Community Ment Health J. 44:261–270, 2008.
New York State Office of Mental Health; Guidance regarding the use of PRN medications. Office of the Medical Director Guidance Memo. 29 April 2010. http://www.omh.ny.gov/omhweb/advisories/prn_meds.pdf.
Conflict of interest
The authors declare that they have no conflict of interest.
Informed Consent
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayes, A., Russ, M.J. Discontinuing the Use of PRN Intramuscular Medication for Agitation in an Acute Psychiatric Hospital. Psychiatr Q 87, 25–29 (2016). https://doi.org/10.1007/s11126-015-9359-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-015-9359-1